Neil Johnson, PhD
Richard Pomerantz, PhD
Richard Pomerantz, PhD
Vasily Studitsky, PhD
Vasily Studitsky, PhD
Italo Tempera, PhD
Kuang-Yi Wen, PhD
Kuang-Yi Wen, PhD
The Fox Chase Cancer Center is pleased to announce the first winners of its new privately funded pilot project grants. The program supports cutting-edge projects that are potentially paradigm-shifting; possess a high likelihood to lead to significant peer-reviewed funding; address community needs; and/or translate laboratory findings into new clinical treatments.
The grants were created this past April as part of the Special Pledge at the annual In Vino Vita Benefit and Wine Auction, Fox Chase Cancer Center’s signature fundraising event. They will include funding of $75,000 per year. Two awards were reserved for junior faculty. A second competition for the next five awards will be held in the fall of 2018.
Winning Projects
The winning projects were selected from a competitive field of 44 submissions. The winners are:
- Sergei Grivennikov, PhD, for Tumor Adherent Microbiota as a Driver of Tumor-Elicited Inflammation in Colorectal Cancer
- Neil Johnson, PhD, for Targeting the Ubiquitin-Regulated DNA Damage Response in BRCA1-Mutant Cancers
- Richard Pomerantz, PhD, for Discovery of a Novel Reverse Transcriptase in Human Cells: Polymerase Θ
- Vasily Studitsky, PhD, and Italo Tempera, PhD, for Mechanisms of PARP1 Action in Transcription
- Kuang-Yi Wen, PhD, for To Reduce Cancer Disparities: Mobile TXT to Improve Hormone Therapy Adherence in African American Breast Cancer Survivors.
The Fifth AnnualIn Vino Vita will be held on Saturday, April 21, 2018. ■
